|
WO2021018116A1
|
|
Tumour marker and use thereof
|
|
WO2020103905A1
|
|
Prognostic markers in lung cancer, prognostic typing model of lung cancer, and application thereof
|
|
WO2020103794A1
|
|
Marker used to detect invasive bladder cancer, and application thereof
|
|
WO2020098604A1
|
|
Grading model for determining benign and malignant degree of prostate tumors and use thereof
|
|
WO2020052520A1
|
|
Hierarchical model for detecting benign and malignant degree of skin tumors and application thereof
|
|
WO2020024911A1
|
|
Grading model for detecting benign and malignant degrees of thyroid tumors, and application thereof
|
|
AU2019302917A1
|
|
Grading model used for detecting degree to which lung tumors are benign and malignant, and application thereof
|
|
WO2020082642A1
|
|
Grading model for detecting benign and malignant degree of pancreatic tumor, and use thereof
|
|
WO2019129144A1
|
|
Grading model for detecting degree of malignancy of esophageal neoplasm and/or gastric neoplasm and use thereof
|
|
WO2019105381A1
|
|
Grading model for detecting benign and malignant degrees of breast turmors and application thereof
|
|
WO2019042380A1
|
|
Hierarchical model for detecting benign and malignant degrees of colorectal tumors and application thereof
|
|
WO2018219342A1
|
|
Imprinted gene graded model and diagnostic method and application
|
|
WO2018214845A1
|
|
Model, diagnostic method, and application thereof
|
|
EP3633045A1
|
|
Model, diagnostic method, and application thereof
|
|
EP3795693A1
|
|
Method for diagnosing cancer by means of biopsy cell sample
|
